fda warning letters compounded semaglutide tirzepatide september 2025 GLP-1 Compounding: When Innovation May Mean Liability Beyond the Headlines: FDA Warning

DS-8500a, an orally available G protein-coupled receptor 119 agonist, upregulates glucagon-like peptide-1 and enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats

GLP-1 medications are safe, FDA-approved treatments that have been extensively studied in clinical trials

However, compounding pharmacies that follow strict regulations set by the state boards of pharmacy, FDA, and DEA are permitted to compound certain medications under the Drug Quality and Security Act (DQSA)

Contact your healthcare provider immediately if you experience severe abdominal pain, persistent vomiting lasting over 24 hours, signs of dehydration, rapid heart rate, or severe headache

How to Reduce Side Effects Simple habits can help: Eat smaller meals: Large portions often worsen nausea

Thus, GLP-1 medications stand alone as true medications of the century. They deliver unparalleled multifaceted benefits across a broad patient spectrum, impacting cardiovascular, renal, hepatic, reproductive, neurological, and oncologic health